Karen A Johnson

A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.

William E Grizzle, Matthew S Mayo, N. Boyd, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.